Primicerio Giulia Carolina, Bille Margrethe B, Lund Eva Løbner, Birk Steffen
Department of Clinical Neurophysiology, Rigshospitalet, Copenhagen, Denmark.
Department of Clinical Neurophysiology, Rigshospitalet, Copenhagen, Denmark.
J Neurol Sci. 2025 Jul 15;474:123536. doi: 10.1016/j.jns.2025.123536. Epub 2025 May 11.
Various peripheral neuropathies, from facial palsy to Guillain-Barre Syndrome, following vaccination have been reported in several different vaccination contexts. However, the relation between small fiber neuropathy and vaccination is still unclear. In the context of COVID-19 vaccination it is even more difficult to assess a secure causality due to the short time that has elapsed since the vaccination, thus research on possible pathophysiology is still in progress. Nonetheless, due to the extensive vaccination campaign held for COVID-19 since 2021, we were able to collect and describe clinical and electrophysiological data of 16 patients with suspected small fiber neuropathy following vaccination, of which 9 fulfilled the criteria for diagnosis of SFN. Defining the causality is arduous, but temporality, analogies with other vaccinations and/or infections support our hypothesis. We underline the importance of post-marketing surveillance to detect rare adverse effects and consequently tailor future studies.
在几种不同的疫苗接种情况下,已经报道了各种周围神经病变,从面瘫到吉兰-巴雷综合征。然而,小纤维神经病变与疫苗接种之间的关系仍不明确。在新冠病毒疫苗接种的背景下,由于自接种以来时间较短,评估确切的因果关系更加困难,因此关于可能的病理生理学的研究仍在进行中。尽管如此,由于自2021年以来针对新冠病毒开展了广泛的疫苗接种运动,我们能够收集并描述16例接种后疑似小纤维神经病变患者的临床和电生理数据,其中9例符合小纤维神经病变的诊断标准。确定因果关系很艰巨,但时间顺序、与其他疫苗接种和/或感染的类比支持了我们的假设。我们强调上市后监测对于发现罕见不良反应并因此调整未来研究的重要性。